Plasmapheresis in hypertriglyceridemia-related pancreatitis: a case report


Submitted: 11 February 2013
Accepted: 11 February 2013
Published: 19 July 2012
Abstract Views: 1342
PDF: 955
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Hypertriglyceridemia (HTG) is the third most common cause of acute pancreatitis (AP), accounting for up to 7% of cases. The clinical manifestations are similar to those of AP from other causes, but it may be difficult to recognize because of confounding laboratory investigations induced by HTG, such as a falsely normal serum amylase. Prompt recognition is important to provide adequate treatment. The maintenance of blood triglyceride (TG) levels below 500 mg/dl has been shown to accelerate the clinical improvement in patients with hypertriglyceridemic pancreatitis (HTGP). In many cases series apheresis was effective in reducing HTG and an early initiation is likely to be beneficial in order to prevent recurrence of AP and the development of necrotizing pancreatitis. Definitive guidelines for the treatment of HTGP and randomized trials that compare the effectiveness of apheresis with the medical therapy alone are still lacking.

Tampieri, A., Cenni, P., Morselli, C., & Lenzi, T. (2012). Plasmapheresis in hypertriglyceridemia-related pancreatitis: a case report. Emergency Care Journal, 8(2), 9–12. https://doi.org/10.4081/ecj.2012.2.9

Downloads

Download data is not yet available.

Citations